Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI
Crossref DOI link: https://doi.org/10.1038/sc.2016.49
Published Online: 2016-04-26
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anquetil, C
Abdelhamid, S
Gelis, A
Fattal, C
Text and Data Mining valid from 2016-04-26
Article History
Received: 26 August 2015
Revised: 17 February 2016
Accepted: 10 March 2016
First Online: 26 April 2016
Competing interests
: The authors declare no conflict of interest.